Literature DB >> 1586058

The effect of maternal smoking during pregnancy on early infant lung function.

J P Hanrahan1, I B Tager, M R Segal, T D Tosteson, R G Castile, H Van Vunakis, S T Weiss, F E Speizer.   

Abstract

We studied the effect of prenatal maternal cigarette smoking on the pulmonary function (PF) of 80 healthy infants tested shortly after birth (mean, 4.2 +/- 1.9 wk). Mothers' prenatal smoking was measured by: (1) questionnaire reports at each prenatal visit of the number of cigarettes smoked per day, and (2) urine cotinine concentrations (corrected for creatinine) obtained at each visit. Infant PF was assessed by partial expiratory flow-volume curves and helium-dilution measurement of FRC. Forced expiratory flow rates were significantly lower in infants born to smoking mothers, both when unadjusted and after controlling for infant size, age, sex, and passive exposure to environmental tobacco smoke (ETS) between birth and the time of PF testing. Flow at functional residual capacity (VFRC) in infants born to smoking mothers was lower than that found in infants whose mothers did not smoke during pregnancy (74.3 +/- 15.9 versus 150.4 +/- 8.9 ml/s; p = 0.0007). Differences remained significant when flow was corrected for lung size (VFRC/FRC: 0.87 +/- 0.26 versus 1.77 +/- 0.12 s-1; p = 0.013). No differences in pulmonary function were evident among infants exposed and unexposed to ETS in the home after stratifying by prenatal exposure status. We conclude that maternal smoking during pregnancy is associated with significant reductions in forced expiratory flow rates in young infants. The results suggest that maternal smoking during pregnancy may impair in utero airway development and/or alter lung elastic properties. We speculate that these effects of maternal prenatal smoking on early levels of forced expiratory flow may be an important factor predisposing infants to the occurrence of wheezing illness later in childhood.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1586058     DOI: 10.1164/ajrccm/145.5.1129

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  127 in total

Review 1.  Gender differences in airway behaviour over the human life span.

Authors:  M R Becklake; F Kauffmann
Journal:  Thorax       Date:  1999-12       Impact factor: 9.139

Review 2.  Socioeconomic status and chronic obstructive pulmonary disease.

Authors:  E Prescott; J Vestbo
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

3.  Maternal smoking during pregnancy, environmental tobacco smoke exposure and childhood lung function.

Authors:  F D Gilliland; K Berhane; R McConnell; W J Gauderman; H Vora; E B Rappaport; E Avol; J M Peters
Journal:  Thorax       Date:  2000-04       Impact factor: 9.139

4.  Introduction

Authors: 
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

Review 5.  Pediatric origins of adult lung disease. 1. The contribution of airway development to paediatric and adult lung disease.

Authors:  S Stick
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

Review 6.  Paediatric origins of adult lung disease.

Authors:  E von Mutius
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

7.  Health effects of passive smoking. 9. Parental smoking and spirometric indices in children.

Authors:  D G Cook; D P Strachan; I M Carey
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

8.  Influence of smoking on asthmatic symptoms and allergen sensitisation in early childhood.

Authors:  S M Tariq; E A Hakim; S M Matthews; S H Arshad
Journal:  Postgrad Med J       Date:  2000-11       Impact factor: 2.401

9.  Airway function at one year: association with premorbid airway function, wheezing, and maternal smoking.

Authors:  C Dezateux; J Stocks; A M Wade; I Dundas; M E Fletcher
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

10.  Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study.

Authors:  Debra A Stern; Wayne J Morgan; Anne L Wright; Stefano Guerra; Fernando D Martinez
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.